Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

6
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
6
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

6
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
6
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

7
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
7
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

7
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
7
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

7
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
7
Goiter01:27

Goiter

3
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Health, Anxiety, Depression, and Stress in Pregnancy: A Rapid Review of Associations and Implications for Perinatal Care.

International journal of environmental research and public health·2025
Same author

Evidence-Based Eating Patterns and Behavior Changes to Limit Excessive Gestational Weight Gain: A Scoping Review.

International journal of environmental research and public health·2024
Same author

Pairing Evidence-Based Strategies With Motivational Interviewing to Support Optimal Nutrition and Weight Gain in Pregnancy.

The Journal of perinatal & neonatal nursing·2024
Same author

Social Determinants of Health Among Pregnant Hispanic Women and Associated Psychological Outcomes.

Journal of racial and ethnic health disparities·2023
Same author

Tryptophan metabolism and immune alterations in pregnant Hispanic women with chronic Toxoplasma gondii infection.

American journal of reproductive immunology (New York, N.Y. : 1989)·2023
Same author

Editorial on Human Milk as a Biological System.

Journal of human lactation : official journal of International Lactation Consultant Association·2023

Related Experiment Video

Updated: Apr 20, 2026

Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

860

Symptoms and signs associated with postpartum thyroiditis.

Maureen Groer1, Cecilia Jevitt2

  • 1University of South Florida College of Nursing, 12910 Bruce B. Downs Boulevard, Tampa, FL 33612, USA.

Journal of Thyroid Research
|November 19, 2014
PubMed
Summary

Postpartum thyroiditis (PPT) is common in women with thyroid peroxidase (TPO) autoantibodies. Even without PPT, TPO positivity increases the risk of thyroid disease symptoms and stress postpartum.

More Related Videos

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.7K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.4K

Related Experiment Videos

Last Updated: Apr 20, 2026

Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

860
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.7K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.4K

Area of Science:

  • Endocrinology
  • Immunology
  • Women's Health

Background:

  • Postpartum thyroiditis (PPT) is a frequent triphasic autoimmune condition.
  • Thyroid peroxidase (TPO) autoantibodies are associated with PPT.
  • Understanding postpartum thyroid dysfunction is crucial for maternal health.

Purpose of the Study:

  • To evaluate thyroid disease symptoms, physical findings, stress, and TSH levels in postpartum women.
  • To compare outcomes across TPO-negative, TPO-positive, and PPT-positive groups.
  • To identify risks associated with TPO autoantibodies in the postpartum period.

Main Methods:

  • Recruited 631 women in midpregnancy.
  • Determined TPO status to form three postpartum groups: TPO-negative, TPO-positive, and PPT-positive.
  • Compared TSH levels, thyroid symptoms, physical metrics, and stress scores across groups over six months postpartum.

Main Results:

  • 56% of TPO-positive women developed PPT.
  • Significant differences in hypothyroid and hyperthyroid subscale scores were observed between groups (P < .003).
  • PPT-positive women reported the highest symptom severity and stress scores.

Conclusions:

  • Postpartum symptoms can mimic thyroid disease, but are more severe in TPO-positive and PPT-positive women.
  • TPO positivity, even without PPT, elevates the risk for postpartum thyroid-related signs and symptoms.
  • Early identification and monitoring of TPO-positive women may be beneficial.